samrat pharmachem ltd
(SMPM:Bombay Stock Exchange)

Financial Statements for samrat pharmachem ltd (SMPM)

Currency in Millions of Indian Rupees	As of:	Mar 31 2009 Restated INR	Mar 31 2010 Restated INR	Mar 31 2011 Restated INR	Mar 31 2012 INR	4 Year Trend
Revenues		353.4	446.5	434.3	695.4
TOTAL REVENUES		353.4	446.7	434.3	695.5
Cost of Goods Sold		324.9	400.4	393.1	607.7
GROSS PROFIT		28.5	46.2	41.2	87.8
Selling General & Admin Expenses, Total		15.5	15.5	15.9	23.0
Depreciation & Amortization, Total		1.3	1.5	1.6	1.9
Other Operating Expenses		8.5	11.2	1.1	1.1
OTHER OPERATING EXPENSES, TOTAL		25.4	28.2	18.7	26.0
OPERATING INCOME		3.1	18.0	22.5	61.8
Interest Expense		-2.6	-3.0	-0.4	-1.1
Interest and Investment Income		--	--	1.4	2.4
Other Non-Operating Expenses, Total		--	0.0	-2.4	-5.1
Other Non-Operating Income (Expenses)		--	0.0	-2.4	-5.1
Gain (Loss) on Sale of Investments		--	-0.9	--	--
Gain (Loss) on Sale of Assets		--	0.0	--	0.0
EBT, INCLUDING UNUSUAL ITEMS		0.5	14.0	21.1	58.0
Income Tax Expense		1.6	2.7	7.7	20.2
Earnings from Continuing Operations		-1.0	11.3	13.4	37.8
NET INCOME		-1.0	11.3	13.4	37.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-1.0	11.3	13.4	37.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-1.0	11.3	13.4	37.8

Report Data Issue

To contact SAMRAT PHARMACHEM LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.